Cannabis giant Tilray Inc. TLRY saw revenue climb to $210.5 million in 2020. That's a 26% spike compared to what the Nanaimo, Canada-based company reported for 2019.
In Tilray's earnings report published Wednesday afternoon, CEO Brendan Kennedy credited the growth to international medical sales and Canadian adult-use sales, up 191% and 49%, respectively, throughout the fourth quarter.
Tilray also reduced costs by about $57 million compared to the same three-month period in 2019.
"As a result, we now operate with a more focused, efficient and competitive cost structure," he said in a prepared statement.
Related: Exclusive: Aphria, Tilray CEOs Discuss Merger, Hiring And 'No Massive Layoffs'
Q4 Breakdown: Tilray is currently in the midst of closing a merger with fellow Canadian cannabis company Aphria Inc. APHA. The deal should wrap in the second quarter of 2021.
In addition, the company reported:
- A total revenue increase of $56.6 million — up 20.5% compared to the fourth quarter of 2019
- A cannabis segment revenue increase of 46% to $41.2 million
- A net loss of $3 million (it lost $219.8 million for the same period in 2019)
- Adjusted EBITDA of $2.2 million
- Some $261.3 million in cash as of Feb. 16
A 'New' Tilray: Kennedy cited an "increasingly-favorable political environment," as well as the pending transaction with Leamington, Ontario-based Aphria, for positioning Tilray for growth.
"Finally, and as previously stated, the ‘new’ Tilray will achieve over C$100 million in anticipated pre-tax synergies," he added, touting "significant value for stockholders.”
See also: How to Buy Tilray (TLRY) Stock
In addition, the company highlighted its cross-border expansion efforts — namely in Portugal and Spain. Those recent moves allowed Tilray to make its brand of medical cannabis available in 17 countries.
Tilray's stock closed at $31.51 and traded up 10% in after-hours trading.
Courtesy image
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!